CSE Bulletin: Reinstatement - Awakn Life Sciences Corp. (AWKN)

Toronto, Ontario--(Newsfile Corp. - Le 31 mai/May 2024) - Effective immediately, Awakn Life Sciences Corp. will be reinstated for trading. The Company has rectified the situation that gave rise to the

newsfileMay 31 11:14 ET

CSE Bulletin: Suspensions - AWKN, BHCC, BZAM, GLOW, VTAL, JKPT, MEAL,VFI.X, STHZ

Toronto, Ontario--(Newsfile Corp. - Le 8 mai/Mai 2024) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defin

newsfileMay 8 10:45 ET

Awakn Life Sciences Discusses Filing of Financial Statements

Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing medicat

newsfileMay 2 18:00 ET

Canadian Securities Exchange Reports February 2024 Performance Figures

Toronto, Ontario--(Newsfile Corp. - March 15, 2024) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced market statistics for February 2024.February 2024 Operating StatisticsT

newsfileMar 15 07:41 ET